Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof

A neuropeptide Y (NPY) derivative compound of Formula 1,

• wherein R1 is a metal chelating agent;
• EB*is Evans Blue or Evans Blue-lysine;
• R2 is a first linker selected from the group consisting of 1 to 10 amino acids and 4 to 10 polyethylene glycol (PEG);
• R2′ is a second linker selected from the group consisting of 1 to 10 amino acids and 4 to 10 polyethylene glycol (PEG);
• B1 is C4H11B10O3 or S10B12H11;
• and
• NPY derivative is selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, and SEO ID NO. 3.